Challenges in the Early Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adults: Current Perspectives

References

• Broers MC, Bunschoten C, Nieboer D, Lingsma HF, Jacobs BC. Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Neuroepidemiology. 2019;52(3–4):161–172. doi:10.1159/000494291
   PubMed Web of Science ®Google Scholar
• Van den Bergh PY, Rajabally YA. Chronic inflammatory demyelinating polyradiculoneuropathy. Presse Med. 2013;42(6 Pt 2):e203–215. doi:10.1016/j.lpm.2013.01.056
   PubMedGoogle Scholar
• Johnsen B, Fuglsang-Frederiksen A. Electrodiagnosis of polyneuropathy. Neurophysiol Clin Clin Neurophysiol. 2000;30(6):339–351. doi:10.1016/S0987-7053(00)00237-9
   PubMed Web of Science ®Google Scholar
• Tankisi H, Pugdahl K, Johnsen B, Fuglsang-Frederiksen A. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies. Clin Neurophysiol. 2007;118(11):2383–2392. doi:10.1016/j.clinph.2007.07.027
   PubMed Web of Science ®Google Scholar
• Eftimov F, Lucke IM, Querol LA, Rajabally YA, Verhamme C. Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy. Brain. 2020;143(11):3214–3224. doi:10.1093/brain/awaa265
   PubMedGoogle Scholar
• Cocito D, Paolasso I, Antonini G, et al. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2010;17(2):289–294. doi:10.1111/j.1468-1331.2009.02802.x
   PubMed Web of Science ®Google Scholar
• Allen JA, Lewis RA. CIDP diagnostic pitfalls and perception of treatment benefit. Neurology. 2015;85(6):498–504. doi:10.1212/WNL.0000000000001833
   PubMed Web of Science ®Google Scholar
• Hughes RA, Mehndiratta MM, Rajabally YA. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2017;11(11):CD002062. doi:10.1002/14651858.CD002062.pub4
   PubMedGoogle Scholar
• Mehndiratta MM, Hughes RA, Pritchard J. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2015;2015(8):CD003906. doi:10.1002/14651858.CD003906.pub4
   PubMedGoogle Scholar
• Eftimov F, van Schaik I. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options. Curr Opin Neurol. 2013;26(5):496–502. doi:10.1097/WCO.0b013e328363bfa4
   PubMed Web of Science ®Google Scholar
• Bouchard C, Lacroix C, Planté V, et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology. 1999;52(3):498. doi:10.1212/WNL.52.3.498
   PubMed Web of Science ®Google Scholar
• Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision. Eur J Neurol. 2021;28(11):3556–3583. doi:10.1111/ene.14959
   PubMed Web of Science ®Google Scholar
• Van den Bergh PY, Hadden RD, Bouche P, et al. European federation of neurological societies/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European federation of neurological societies and the peripheral nerve society - first revision. Eur J Neurol. 2010;17(3):356–363. doi:10.1111/j.1468-1331.2009.02930.x
   PubMed Web of Science ®Google Scholar
• Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982;32(9):958–964. doi:10.1212/WNL.32.9.958
   PubMed Web of Science ®Google Scholar
• Berg-Vos R, Berg L, Franssen H, et al. Multifocal inflammatory demyelinating neuropathy: A distinct clinical entity? Neurology. 2000;54(1):26 doi:10.1212/WNL.54.1.26.
   PubMed Web of Science ®Google Scholar
• Maisonobe T, Chassande B, Vérin M, Jouni M, Léger JM, Bouche P. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. J Neurol Neurosurg Psychiatr. 1996;61(1):36–42. doi:10.1136/jnnp.61.1.36
   PubMed Web of Science ®Google Scholar
• Oh SJ, Claussen GC, Kim DS. Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy? J Peripher Nerv Syst. 1997;2(4):362–369.
   PubMedGoogle Scholar
• Jeanjean AP, Duprez T, Van den Bergh PY. Massive peripheral nerve hypertrophy in a patient with multifocal upper limb demyelinating neuropathy (Lewis-Sumner syndrome). Acta Neurol Belg. 2001;101(4):234–238.
   PubMed Web of Science ®Google Scholar
• Weiss MD, Oakley JC, Meekins GD. Hypoglossal neuropathy in Lewis-Sumner syndrome masquerading as motor neuron disease. Neurology. 2006;67(1):175–176. doi:10.1212/01.wnl.0000223577.69111.2c
   PubMed Web of Science ®Google Scholar
• Rajabally YA, Chavada G. Lewis-Sumner syndrome of pure upper-limb onset: diagnostic, prognostic, and therapeutic features. Muscle Nerve. 2009;39(2):206–220. doi:10.1002/mus.21199
   PubMed Web of Science ®Google Scholar
• Doneddu PE, Cocito D, Manganelli F, et al. Atypical CIDP: diagnostic criteria, progression and treatment response. data from the Italian CIDP database. J Neurol Neurosurg Psychiatr. 2019;90(2):125–132. doi:10.1136/jnnp-2018-318714
   PubMed Web of Science ®Google Scholar
• Breiner A, Brannagan TH. Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2014;50(1):40–46. doi:10.1002/mus.24088
   PubMed Web of Science ®Google Scholar
• Rajabally YA, Fowle AJ, Van den Bergh PY. Which criteria for research in chronic inflammatory demyelinating polyradiculoneuropathy? An analysis of current practice. Muscle Nerve. 2015;51(6):932–933. doi:10.1002/mus.24496
   PubMed Web of Science ®Google Scholar
• Rajabally YA, Afzal S, Loo LK, Goedee HS. Application of the 2021 EAN/PNS criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatr. 2022;93(12):1247–1252. doi:10.1136/jnnp-2022-329633
   PubMed Web of Science ®Google Scholar
• Doneddu PE, De Lorenzo A, Manganelli F, et al. Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg. 2022;1:329357 doi:10.1136/jnnp-2022-329357.
   Google Scholar
• Herraets IJT, Goedee HS, Telleman JA, et al. Nerve ultrasound improves detection of treatment-responsive chronic inflammatory neuropathies. Neurology. 2020;2020:3 doi:31959710 DOI: 10.1212/wnl.0000000000008978.
   Google Scholar
• Goedee HS, Jongbloed BA, van Asseldonk JH, et al. A comparative study of brachial plexus sonography and magnetic resonance imaging in chronic inflammatory demyelinating neuropathy and multifocal motor neuropathy. Eur J Neurol. 2017;24(10):1307–1313. doi:10.1111/ene.13380
   PubMed Web of Science ®Google Scholar
• Grimm A, Rattay TW, Winter N, Axer H. Peripheral nerve ultrasound scoring systems: benchmarking and comparative analysis. J Neurol. 2017;264(2):243–253. doi:10.1007/s00415-016-8305-y
   PubMed Web of Science ®Google Scholar
• Van Asseldonk JTH, Van den Berg LH, Kalmijn S, Wokke JHJ, Franssen H. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37°C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Brain. 2005;128(4):880–891. doi:10.1093/brain/awh375
   PubMedGoogle Scholar
• Padua L, Caliandro P, Aprile I, Sabatelli M, Madia F, Tonali P. Occurrence of nerve entrapment lesion in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol. 2004;115(5):1140–1144. doi:10.1016/j.clinph.2003.12.007
   PubMed Web of Science ®Google Scholar
• Rajabally YA, Narasimhan M. Electrophysiological entrapment syndromes in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2011;44(3):444–447. doi:10.1002/mus.22146
   PubMed Web of Science ®Google Scholar
• Mondelli M, Aretini A, Arrigucci U, Ginanneschi F, Greco G, Sicurelli F. Clinical findings and electrodiagnostic testing in 108 consecutive cases of lumbosacral radiculopathy due to herniated disc. Neurophysiol Clin. 2013;43(4):205–215. doi:10.1016/j.neucli.2013.05.004
   PubMed Web of Science ®Google Scholar
• Allen JA, Ney J, Lewis RA. Electrodiagnostic errors contribute to chronic inflammatory demyelinating polyneuropathy misdiagnosis. Muscle Nerve. 2018;57(4):542–549. doi:10.1002/mus.25997
   PubMed Web of Science ®Google Scholar
• Lucke IM, Wieske L, van der Kooi AJ, van Schaik IN, Eftimov F, Verhamme C. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst. 2019;24(2):174–179. doi:10.1111/jns.12325
   PubMed Web of Science ®Google Scholar
• Rajabally YA, Jacob S. Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol. 2006;117(9):2079–2084. doi:10.1016/j.clinph.2006.05.028
   PubMed Web of Science ®Google Scholar
• Rajabally YA, Narasimhan M. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol. 2011;18(2):293–299. doi:10.1111/j.1468-1331.2010.03138.x
   PubMed Web of Science ®Google Scholar
• Uncini A, Kuwabara S. Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatr. 2015;86(11):1186–1195. doi:10.1136/jnnp-2014-310097
   PubMed Web of Science ®Google Scholar
• Breiner A, Qrimli M, Ebadi H, et al. Peripheral nerve high-resolution ultrasound in diabetes. Muscle Nerve. 2017;55(2):171–178. doi:10.1002/mus.25223
   PubMed Web of Science ®Google Scholar
• Loewenbruck KF, Dittrich M, Bohm J, et al. Practically applicable nerve ultrasound models for the diagnosis of axonal and demyelinating hereditary motor and sensory neuropathies (HMSN). J Neurol. 2018;265(1):165–177. doi:10.1007/s00415-017-8687-5
   PubMed Web of Science ®Google Scholar
• Herraets IJT, Goedee HS, Telleman JA, et al. Nerve ultrasound for diagnosing chronic inflammatory neuropathy: a multicenter validation study. Neurology. 2020;95(12):e1745–e1753. doi:10.1212/WNL.0000000000010369
   PubMed Web of Science ®Google Scholar
• Matsuoka N, Kohriyama T, Ochi K, et al. Detection of cervical nerve root hypertrophy by ultrasonography in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci. 2004;219(1–2):15–21. doi:10.1016/j.jns.2003.11.011
   PubMed Web of Science ®Google Scholar
• Zaidman CM, Al-Lozi M, Pestronk A. Peripheral nerve size in normals and patients with polyneuropathy: an ultrasound study. Muscle Nerve. 2009;40(6):960–966. doi:10.1002/mus.21431
   PubMed Web of Science ®Google Scholar
• Sugimoto T, Ochi K, Hosomi N, et al. Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy. J Neurol. 2013;260(10):2580–2587. doi:10.1007/s00415-013-7021-0
   PubMed Web of Science ®Google Scholar
• Telleman JA, Herraets IJT, Goedee HS, et al. Nerve ultrasound: a reproducible diagnostic tool in peripheral neuropathy. Neurology. 2019;92(5). doi:10.1212/WNL.0000000000006856
   PubMed Web of Science ®Google Scholar
• Goedee HS, van der Pol WL, Hendrikse J, van den Berg LH. Nerve ultrasound and magnetic resonance imaging in the diagnosis of neuropathy. Curr Opin Neurol. 2018;31(5):526–533. doi:10.1097/WCO.0000000000000607
   PubMed Web of Science ®Google Scholar
• van Rosmalen MHJ, Goedee HS, van der Gijp A, et al. Low interrater reliability of brachial plexus MRI in chronic inflammatory neuropathies. Muscle Nerve. 2020;61(6):779–783. doi:10.1002/mus.26821
   PubMed Web of Science ®Google Scholar
• Oudeman J, Eftimov F, Strijkers GJ, et al. Diagnostic accuracy of MRI and ultrasound in chronic immune-mediated neuropathies. Neurology. 2020;94(1):e62–e74. doi:10.1212/WNL.0000000000008697
   PubMed Web of Science ®Google Scholar
• Jomier F, Bousson V, Viala K, et al. Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy. Eur J Neurol. 2020;27(1):181–187. doi:10.1111/ene.14053
   PubMed Web of Science ®Google Scholar
• Lozeron P, Lacour MC, Vandendries C, et al. Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies. J Neurol Sci. 2016;360:170–175. doi:10.1016/j.jns.2015.11.048
   PubMed Web of Science ®Google Scholar
• Tanaka K, Mori N, Yokota Y, Suenaga T. MRI of the cervical nerve roots in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy: a single-institution, retrospective case-control study. BMJ Open. 2013;3(8):e003443. doi:10.1136/bmjopen-2013-003443
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. 1975;50(11):621–637.
   PubMed Web of Science ®Google Scholar
• Prineas JW, McLeod JG. Chronic relapsing polyneuritis. J Neurol Sci. 1976;27(4):427–458. doi:10.1016/0022-510X(76)90213-6
   PubMed Web of Science ®Google Scholar
• McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and electrophysiological study of 92 cases. Brain. 1987;110(6):1617–1630. doi:10.1093/brain/110.6.1617
   PubMedGoogle Scholar
• Bouché P, Gherardi R, Cathala HP, Lhermitte F, Castaigne P. Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study. J Neurol Sci. 1983;61(3):389–399. doi:10.1016/0022-510X(83)90172-7
   PubMed Web of Science ®Google Scholar
• Kobessho H, Oishi K, Hamaguchi H, Kanda F. Elevation of cerebrospinal fluid protein in patients with diabetes mellitus is associated with duration of diabetes. Eur Neurol. 2008;60(3):132–136. doi:10.1159/000144083
   PubMed Web of Science ®Google Scholar
• Breiner A, Bourque PR, Allen JA. Updated cerebrospinal fluid total protein reference values improve chronic inflammatory demyelinating polyneuropathy diagnosis. Muscle Nerve. 2019;60(2):180–183. doi:10.1002/mus.26488
   PubMed Web of Science ®Google Scholar
• Liberatore G, Manganelli F, Cocito D, et al. Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: data from the Italian CIDP database. J Peripher Nerv Syst. 2020;25(2):152–161. doi:10.1111/jns.12378
   Web of Science ®Google Scholar
• Press R, Pashenkov M, Jin JP, Link H. Aberrated levels of cerebrospinal fluid chemokines in guillain-barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Immunol. 2003;23(4):259–267. doi:10.1023/A:1024532715775
   PubMed Web of Science ®Google Scholar
• van Doorn PA, Vermeulen M, Brand A, Mulder PGH, Busch HFM. Intravenous Immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: clinical and laboratory characteristics associated with improvement. Arch Neurol. 1991;48(2):217–220. doi:10.1001/archneur.1991.00530140113024
   PubMedGoogle Scholar
• Lucke IM, Peric S, van Lieverloo GGA, et al. Elevated leukocyte count in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst. 2018;23(1):49–54. doi:10.1111/jns.12250
   PubMed Web of Science ®Google Scholar
• Querol L, Siles AM, Alba-Rovira R, et al. Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy. Sci Rep. 2017;7(1). doi:10.1038/s41598-017-14853-4
   Google Scholar
• Vural A, Doppler K, Meinl E. Autoantibodies against the node of Ranvier in seropositive chronic inflammatory demyelinating polyneuropathy: diagnostic, pathogenic, and therapeutic relevance. Front Immunol. 2018;9:1029. doi:10.3389/fimmu.2018.01029
   PubMed Web of Science ®Google Scholar
• Collet R, Caballero-Avila M, Querol L. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies. Rev Neurol. 2023;179(8):831–843. doi:10.1016/j.neurol.2023.02.064
   PubMedGoogle Scholar
• Sakamoto Y, Shimizu T, Tobisawa S, Isozaki E. Chronic demyelinating neuropathy with anti-myelin-associated glycoprotein antibody without any detectable M-protein. Neurol Sci. 2017;38(12):2165–2169. doi:10.1007/s10072-017-3133-0
   PubMed Web of Science ®Google Scholar
• Pascual-Goni E, Martin-Aguilar L, Lleixa C, et al. Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy. Sci Rep. 2019;9(1):6155. doi:10.1038/s41598-019-42545-8
   PubMedGoogle Scholar
• Liberatore G, Giannotta C, Sajeev BP, et al. Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy. J Neuroimmunol. 2020;345:577288. doi:10.1016/j.jneuroim.2020.577288
   PubMed Web of Science ®Google Scholar
• Sommer C, Koch S, Lammens M, Gabreels-Festen A, Stoll G, Toyka KV. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology. 2005;65(12):1924–1929. doi:10.1212/01.wnl.0000188879.19900.b7
   PubMed Web of Science ®Google Scholar
• Bosboom WM, van den Berg LH, Franssen H, et al. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain. 2001;124(Pt 12):2427–2438. doi:10.1093/brain/124.12.2427
   PubMedGoogle Scholar
• Krendel DA, Parks HP, Anthony DC, St Clair MB, Graham DG. Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1989;12(4):257–264. doi:10.1002/mus.880120402
   PubMed Web of Science ®Google Scholar
• Garces-Sanchez M, Laughlin RS, Dyck PJ, Engelstad JK, Norell JE, Dyck PJ. Painless diabetic motor neuropathy: a variant of diabetic lumbosacral radiculoplexus Neuropathy? Ann Neurol. 2011;69(6):1043–1054. doi:10.1002/ana.22334
   PubMed Web of Science ®Google Scholar
• Vallat JM, Tabaraud F, Magy L, et al. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve. 2003;27(4):478–485. doi:10.1002/mus.10348
   PubMed Web of Science ®Google Scholar
• Lee LY, Tan CY, Wong KT, Goh KJ, Shahrizaila N. Diagnostic yield of nerve biopsy in the evaluation of peripheral neuropathies. J Clin Neurosci. 2023;107:40–47. doi:10.1016/j.jocn.2022.11.017
   PubMed Web of Science ®Google Scholar
• Oaklander AL, Lunn MPT, Hughes RAC, van Schaik IN, Frost C, Chalk CH. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database Syst Rev. 2017;2017(1). doi:10.1002/14651858.CD010369.pub2
   Google Scholar
• Eftimov F, Winer JB, Vermeulen M, de Haan R, van Schaik IN. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2013. doi:10.1002/14651858.CD001797.pub3
   PubMed Web of Science ®Google Scholar
• Burt RK, Tappenden P, Balabanov R, et al. The cost effectiveness of immunoglobulin vs. Hematopoietic stem cell transplantation for CIDP. Front Neurol. 2021;12:645263. doi:10.3389/fneur.2021.645263
   PubMed Web of Science ®Google Scholar
• Donofrio PD, Bril V, Dalakas MC, et al. Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol. 2010;67(9):1082–1088. doi:10.1001/archneurol.2010.223
   PubMedGoogle Scholar
• Kapoor M, Hunt I, Spillane J, et al. IVIg-exposure and thromboembolic event risk: findings from the UK Biobank. J Neurol Neurosurg Psychiatr. 2022;93(8):876–885. doi:10.1136/jnnp-2022-328881
   PubMed Web of Science ®Google Scholar
• Querol L, Rojas-Garcia R, Casasnovas C, et al. Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study. Muscle Nerve. 2013;48(6):870–876. doi:10.1002/mus.23843
   PubMed Web of Science ®Google Scholar
• Nobile-Orazio E, Cocito D, Jann S, et al. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP. J Neurol Neurosurg Psychiatr. 2015;86(7):729–734. doi:10.1136/jnnp-2013-307515
   PubMed Web of Science ®Google Scholar
• Rabin M, Mutlu G, Stojkovic T, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal. J Neurol Neurosurg. 2014;85(8):901–906. doi:10.1136/jnnp-2013-306105
   PubMed Web of Science ®Google Scholar
• van Schaik IN, Bril V, van Geloven N, et al. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, Phase 3 trial. Lancet Neurol. 2018;17(1):35–46. doi:10.1016/S1474-4422(17)30378-2
   PubMed Web of Science ®Google Scholar
• Svacina MKR, Meissner A, Schweitzer F, et al. Immunomodulatory effects of intravenous and subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an observational study. Eur J Neurol. 2023;2:4 doi:10.1111/ene.16079.
   Google Scholar
• Markvardsen LH, Sindrup SH, Christiansen I, et al. Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study. Eur J Neurol. 2017;24(2):412–418. doi:10.1111/ene.13218
   PubMed Web of Science ®Google Scholar
• van Schaik IN, Eftimov F, van Doorn PA, et al. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol. 2010;9(3):245–253. doi:10.1016/S1474-4422(10)70021-1
   PubMed Web of Science ®Google Scholar
• van Lieverloo GGA, Peric S, Doneddu PE, et al. Corticosteroids in chronic inflammatory demyelinating polyneuropathy: a retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone. J Neurol. 2018;265(9):2052–2059. doi:10.1007/s00415-018-8948-y
   PubMedGoogle Scholar
• Eftimov F, Vermeulen M, van Doorn PA, Brusse E, van Schaik IN. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment. Neurology. 2012;78(14):1079–1084. doi:10.1212/WNL.0b013e31824e8f84
   PubMed Web of Science ®Google Scholar
• Nobile-Orazio E, Cocito D, Jann S, et al. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol. 2012;11(6):493–502. doi:10.1016/S1474-4422(12)70093-5
   PubMed Web of Science ®Google Scholar
• Sabatelli M, Madia F, Mignogna T, Lippi G, Quaranta L, Tonali P. Pure motor chronic inflammatory demyelinating polyneuropathy. J Neurol. 2001;248(9):772–777. doi:10.1007/s004150170093
   PubMed Web of Science ®Google Scholar
• Kimura A, Sakurai T, Koumura A, et al. Motor-dominant chronic inflammatory demyelinating polyneuropathy. J Neurol. 2010;257(4):621–629. doi:10.1007/s00415-009-5386-x
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Daube J, O’Brien P, et al. Plasma Exchange in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. N Engl J Med. 1986;314(8):461–465. doi:10.1056/NEJM198602203140801
   PubMed Web of Science ®Google Scholar
• Hahn AF, Bolton CF, Pillay N, et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: a double-blind, sham-controlled, cross-over study. Brain. 1996;119(4):1055–1066. doi:10.1093/brain/119.4.1055
   PubMedGoogle Scholar
• Mortzell Henriksson M, Newman E, Witt V, et al. Adverse events in apheresis: an update of the WAA registry data. Transfus Apher Sci. 2016;54(1):2–15. doi:10.1016/j.transci.2016.01.003
   PubMed Web of Science ®Google Scholar
• van Veen R, Wieske L, Lucke I, et al. Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: a post-hoc analysis of the immunoglobulin overtreatment in CIDP trial. J Peripher Nerv Syst. 2022;27(2):144–158. doi:10.1111/jns.12497
   PubMed Web of Science ®Google Scholar
• Kaplan A, Brannagan TH. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2017;55(4):476–482. doi:10.1002/mus.25271
   PubMed Web of Science ®Google Scholar
• Allen JA, Lewis RA. Diagnosis of chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2022;66(5):545–551. doi:10.1002/mus.27708
   PubMed Web of Science ®Google Scholar
• Lewis RA, van Doorn PA, Sommer C. Tips in navigating the diagnostic complexities of chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci. 2022;443:120478. doi:10.1016/j.jns.2022.120478
   PubMed Web of Science ®Google Scholar
• Allen JA, Lewis RA. Treatment of chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2022;66(5):552–557. doi:10.1002/mus.27709
   PubMed Web of Science ®Google Scholar
• Doneddu PE, Hadden RDM. Daily grip strength response to intravenous immunoglobulin in chronic immune neuropathies. Muscle Nerve. 2020;62(1):103–110. doi:10.1002/mus.26898
   PubMed Web of Science ®Google Scholar